However, with a growing body of evidence elucidating the significant roles IRAK1 plays in tumorigenesis, a significant increase in future studies that utilize IRAK1 inhibitors in combination with conventional treatment modalities is anticipated, aiming to achieve synergistic outcomes in combating cancer metastasis and treatment resistance. The gene discussed is IRAK1; the disease is cancer.